BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25222421)

  • 1. Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding.
    Akl EA; Guyatt GH
    Ann Intern Med; 2014 Sep; 161(6):JC8-9. PubMed ID: 25222421
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolytic therapy for pulmonary embolism.
    Beckman JA
    JAMA; 2014 Jun; 311(23):2385-6. PubMed ID: 24938561
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefits and risks associated with thrombolysis for pulmonary embolism.
    Bova C
    JAMA; 2014 Oct; 312(15):1589. PubMed ID: 25321915
    [No Abstract]   [Full Text] [Related]  

  • 4. Benefits and risks associated with thrombolysis for pulmonary embolism.
    Bradford MA; Adhikari NK; Friedrich JO
    JAMA; 2014 Oct; 312(15):1588-9. PubMed ID: 25321914
    [No Abstract]   [Full Text] [Related]  

  • 5. Benefits and risks associated with thrombolysis for pulmonary embolism--reply.
    Chatterjee S; Giri J
    JAMA; 2014 Oct; 312(15):1589-90. PubMed ID: 25321916
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
    Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J
    JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy in patients with submassive pulmonary embolism.
    Dalen JE
    N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542064
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolytic therapy for acute pulmonary embolism: when do the benefits exceed the risks?
    Stein PD; Dalen JE
    Am J Med; 2014 Nov; 127(11):1031-1032. PubMed ID: 25019361
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH Score.
    Chatterjee S; Weinberg I; Yeh RW; Chakraborty A; Sardar P; Weinberg MD; Kabrhel C; Barnes GD; Mukherjee D; Kumbhani D; Bashir R; Vaidya A; Smith A; Fuchs B; Groeneveld P; Giri J
    Thromb Haemost; 2017 Jan; 117(2):246-251. PubMed ID: 27882375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary embolism: whom to discharge and whom to thrombolyze?
    Meyer G; Planquette B; Sanchez O
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S252-8. PubMed ID: 26149032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial hemorrhage in a patient with sub-massive pulmonary embolism treated with EkoSonic endovascular system directed thrombolysis.
    Ganatra S; Majithia A; Yeh YE; Levy MS
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):476-479. PubMed ID: 28398633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic thrombolysis for acute pulmonary embolism.
    Bartel B
    Hosp Pract (1995); 2015; 43(1):22-7. PubMed ID: 25559613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pulmonary embolism: anticoagulation, thrombolytic therapy, and complications of therapy.
    Tapson VF
    Crit Care Clin; 2011 Oct; 27(4):825-39, vi. PubMed ID: 22082516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
    Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
    Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anuria due to acute bilateral renal vein occlusion after thrombolysis for pulmonary embolism.
    Zakynthinos E; Douka E; Daniil Z; Konstantinidis K; Markaki V; Zakynthinos S
    Int J Cardiol; 2005 May; 101(1):163-6. PubMed ID: 15860405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of thrombolytic therapy in the treatment of pulmonary embolism.
    Pini M
    Haematologica; 1997; 82(3):258-61. PubMed ID: 9234569
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intracranial hemorrhage due to pulmonary thromboembolism in heparin therapy and therapeutic management of patients hospitalized with massive pulmonary embolism after discharge].
    Basr C
    Turk Kardiyol Dern Ars; 2013 Sep; 41(6):571. PubMed ID: 24364065
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic therapy for venous thromboembolism. Complications and contraindications.
    Levine MN
    Clin Chest Med; 1995 Jun; 16(2):321-8. PubMed ID: 7656543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Thrombolysis, Catheter-Directed Thrombolysis, and Anticoagulation for Intermediate-risk Pulmonary Embolism: A Simulation Modeling Analysis.
    Kabrhel C; Ali A; Choi JG; Hur C
    Acad Emerg Med; 2017 Oct; 24(10):1235-1243. PubMed ID: 28650086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary antiphospholipid syndrome with recurrent coronary thrombosis, acute pulmonary thromboembolism and intracerebral hematoma.
    Prashanth P; Mukhaini MK
    J Invasive Cardiol; 2009 Dec; 21(12):E254-8. PubMed ID: 19966379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.